BioSpace News Archive

Stealth BioTherapeutics announced that it has issued an additional 588,232 American Depositary Shares at the public offering price of $12.00 per ADS, resulting in additional gross proceeds of approximately $7.1 million, pursuant to the exercise in part of the underwriters’ over-allotment option in connection with Stealth’s previously announced initial public offering of ADSs.

Offering proceeds, along with balance sheet cash, expected to fund a debt reduction of ~$550 million

Assistance for UnitedHealthcare plan participants whose access to care or prescriptions needs may have been affected

NovaGo Therapeutics AG, a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke, has closed a Series A financing round of CHF 10 million led by Pureos Bioventures and the strategic partner Neurimmune.

BOC Sciences, a US-based global manufacturer of high-quality chemicals and efficient custom services to support the pharmaceutical industry through all stages of drug discovery, has recently added intermediates synthesis to its API synthesis portfolio.

MGI’s “Broadband” Sequencing Delivers Bandwidth to Achieve Genome for All Vision

PTC Therapeutics, Inc. announced that management will present a company update at the following conferences

Banner – University Medical Center Phoenix and Banner Del E. Webb Medical Center have been named to the nation’s 100 Top Hospitals list by IBM Watson HealthTM.

Emmes announced that Behrman Capital, a leading private equity firm, has made a significant investment in the company.

Pfizer Inc. announced the pricing of a debt offering consisting of five tranches of notes: